These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30548592)

  • 21. Efficacy of acitretin in severe psoriasis.
    Geiger JM
    Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.
    Zhang CS; Yang L; Zhang AL; May BH; Yu JJ; Guo X; Lu C; Xue CC
    J Altern Complement Med; 2016 Mar; 22(3):174-88. PubMed ID: 26919330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study.
    Kampitak T; Asawanonda P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S20-4. PubMed ID: 17718265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythroderma in a patient taking acitretin for plaque psoriasis.
    Ahdout J; Mandel H; Chiu M
    J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New roles for systemic retinoids.
    Lebwohl M; Kathryn M
    J Drugs Dermatol; 2006 May; 5(5):406-9. PubMed ID: 16703775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma miR-126 expression correlates with risk and severity of psoriasis and its high level at baseline predicts worse response to Tripterygium wilfordii Hook F in combination with acitretin.
    Duan Y; Zou J; Mao J; Guo D; Wu M; Xu N; Zhou J; Zhang Y; Guo W; Jin W
    Biomed Pharmacother; 2019 Jul; 115():108761. PubMed ID: 31100542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acitretin on the liver.
    Roenigk HH; Callen JP; Guzzo CA; Katz HI; Lowe N; Madison K; Nigra T; Fiedler VC; Armstrong RB
    J Am Acad Dermatol; 1999 Oct; 41(4):584-8. PubMed ID: 10495381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.
    Campalani E; Allen MH; Fairhurst D; Young HS; Mendonca CO; Burden AD; Griffiths CE; Crook MA; Barker JN; Smith CH
    Br J Dermatol; 2006 Feb; 154(2):345-52. PubMed ID: 16433808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result.
    Ricceri F; Pescitelli L; Tripo L; Bassi A; Prignano F
    Dermatol Ther; 2013; 26(1):77-8. PubMed ID: 23384024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
    Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
    Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
    Yu C; Fan X; Li Z; Liu X; Wang G
    Eur J Dermatol; 2017 Apr; 27(2):150-154. PubMed ID: 28400341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose acitretin in treatment of plaque-type psoriasis: descriptive study of efficacy and safety.
    Borghi A; Corazza M; Bertoldi AM; Caroppo F; Virgili A
    Acta Derm Venereol; 2015 Mar; 95(3):332-6. PubMed ID: 24978351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of morphea and psoriasis responding to acitretin treatment.
    Bilen N; Apaydin R; Erçin C; Harova G; Başdaş F; Bayramgürler D
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):113-7. PubMed ID: 10568490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of low-dose acitretin in the treatment of psoriasis.
    Haushalter K; Murad EJ; Dabade TS; Rowell R; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2012 Dec; 23(6):400-3. PubMed ID: 21787207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low-dose acitretin treatment on pituitary hormones in psoriasis vulgaris: A retrospective study.
    Karadag AS; Ozlu E; Kostek O; Bilgili SG; Balaharoglu R; Ertugrul DT
    Indian J Dermatol Venereol Leprol; 2019; 85(3):300-304. PubMed ID: 29855455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety and efficacy of continuous acitretin monotherapy for three children with different severe hyperkeratotic disorders in China.
    Liang J; Chen P; Chen H; Tian X; Wu Z; Zhang S; Li C; Zhang X
    J Dermatol; 2018 Aug; 45(8):1003-1008. PubMed ID: 29756235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acitretin Use in Dermatology.
    Guenther LC; Kunynetz R; Lynde CW; Sibbald RG; Toole J; Vender R; Zip C
    J Cutan Med Surg; 2017; 21(3_suppl):2S-12S. PubMed ID: 28952335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.